Health Care • Biotechnology: Electromedical & Electrotherapeutic Apparatus
$49.63 ▲ +0.38
(+0.77%)
MKT CAP: $2.96B • VOL: 2.28M
52W L $22 52W H $53
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$42
MEDIAN
$56
MEAN
$57
HIGH
$68
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE AXGN TAPE
AXGN // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $60.05 | $57.07 | 2025-02-14 | $45.16 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $62.53 | $58.56 | 2025-02-06 | $46.65 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $56.58 | $54.59 | 2025-01-29 | $47.64 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $50.62 | — | 2025-01-17 | $48.64 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $43.67 | $47.15 | 2025-01-09 | $44.17 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $59.06 | $51.62 | 2024-12-18 | $43.18 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $48.14 | $50.13 | 2024-12-04 | $46.16 | -4.3% | 48% | C |